focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 465.00
Bid: 460.00
Ask: 470.00
Change: -3.00 (-0.64%)
Spread: 10.00 (2.174%)
Open: 468.00
High: 468.00
Low: 457.00
Prev. Close: 468.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (TP Group plc)

10 Nov 2022 07:00

RNS Number : 8827F
TP Group PLC
10 November 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TP Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

9 November 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1p each in the capital of TP Group plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

 

Nil

 

(2) Cash-settled derivatives:

 

Nil

 

Nil

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

 

Nil

 

 

TOTAL:

Nil

 

Nil

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary Shares of 1p each in the capital of TP Group plc held by Directors of TP Group plc and their close relatives:

 

Name

No. of Shares

% of Issued Share Capital

David Lindsay (Non-Executive Director)

2,600,000

0.33%

Derren Stroud (Chief Financial Officer)

653,847

0.08%

 

 

b) Options and awards granted under TP Group's share option scheme held by the directors of TP Group plc.

 

No directors of TP Group plc hold any options over ordinary shares in TP Group plc, nor any other rights to subscribe for new ordinary shares.

 

c) Interests or rights to subscribe held by connected advisers of TP Group plc

 

Cenkos Securities plc holds warrants to subscribe for new ordinary shares in TP Group plc:

 

Name

 

Warrant holder

Description of warrants

Number of warrants over new ordinary shares

Grant date

Lapse date

Exercise price

Cenkos Securities plc

Warrants to subscribe for new ordinary shares in TP Group plc

23,375,361

29 September 2021

29 September 2026

5.8p per share

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 November 2022

Contact name:

Derren Stroud, Chief Financial Officer and Company Secretary

 

Telephone number:

Tel: 01753 285802

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEAKFNEFXAFFA
Date   Source Headline
14th Jun 20198:31 amRNSResponse to Science Group's announcement
14th Jun 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
12th Jun 20193:00 pmRNSHolding(s) in Company
6th Jun 20195:43 pmRNSHolding(s) in Company
6th Jun 20193:31 pmRNSTreasury share issued
6th Jun 20193:30 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
29th May 20197:00 amRNSHolding(s) in Company
29th May 20197:00 amRNSTreasury shares issued
23rd May 20197:00 amRNSTreasury shares issued
21st May 20197:00 amRNSHolding(s) in Company
20th May 20197:00 amRNSTermination of Discussions and Holding in Company
20th May 20197:00 amRNSInvestment in Frontier Smart Technologies GroupLtd
25th Apr 20197:00 amRNSBoard Appointment
24th Apr 201912:00 pmRNSResult of Annual General Meeting
28th Mar 20197:00 amRNSPosting of documents to shareholders & AGM notice
26th Mar 20197:00 amRNSTransaction in Own Shares
22nd Mar 20197:00 amRNSTransaction in Own Shares
21st Mar 20197:00 amRNSTransaction in Own Shares
18th Mar 20197:00 amRNSTransaction in Own Shares
8th Mar 20197:00 amRNSTransaction in Own Shares
5th Mar 20197:00 amRNSAudited results for year ended 31 December 2018
26th Feb 20197:00 amRNSNotice of Preliminary Results
21st Feb 20193:15 pmRNSTR1: Notification of Major Interest in Shares
20th Feb 20197:00 amRNSExtended Bank Facilities
24th Jan 20197:00 amRNSCorporate Strategic Review
19th Dec 20187:00 amRNSTransaction in Own Shares
18th Dec 20187:00 amRNSTR1: Notification of Major Interest in Shares
17th Dec 20182:33 pmRNSForm 8.3 - Science Group plc
14th Dec 201812:13 pmRNSForm 8.3 - Science Group plc
14th Dec 20187:00 amRNSTrading Update; Termination of Formal Sale Process
12th Dec 201812:33 pmRNSForm 8.3 - Science Group plc
7th Dec 201812:10 pmRNSForm 8.3 - Science Group plc
3rd Dec 201812:40 pmRNSForm 8.3 - Science Group plc
3rd Dec 20187:00 amRNSTreasury shares issued & Rule 2.9 announcement
30th Nov 201811:02 amRNSForm 8.3 - Science Group plc
29th Nov 201812:04 pmRNSForm 8.3 - Science Group plc
27th Nov 201810:01 amRNSForm 8.3 - Science Group plc
27th Nov 201810:00 amRNSFinance Director maternity leave
26th Nov 20182:23 pmRNSForm 8.3 - Science Group plc
21st Nov 201810:55 amGNWForm 8.3 - [Science Group plc]
21st Nov 20187:58 amRNSForm 8.5 (EPT/RI) - Science Group PLC
15th Nov 20188:56 amRNSForm 8.5 (EPT/RI) - Science Group Plc
14th Nov 20188:15 amRNSForm 8.5 (EPT/RI) - Science Group PLC
13th Nov 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
5th Nov 20189:22 amRNSForm 8.5 (EPT/RI) - Science Group PLC
31st Oct 201810:07 amGNWForm 8.3 - Science Group Plc
30th Oct 20188:16 amRNSForm 8.5 (EPT/RI) - Science Group PLC
29th Oct 20185:24 pmRNSForm 8.3 - Science Group PLC
29th Oct 20187:00 amRNSTreasury shares issued & Rule 2.9 Announcement
24th Oct 20181:29 pmRNSForm 8.3 - Science Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.